Zhao Y, Liu X, Wang L, Pan X, Pan F, Ke Q. MiR-302 targets PAK5 and prevents the transition from chronic hepatitis B to liver cirrhosis. J Pak Med Assoc [Internet]. 2024 Nov. 17 [cited 2025 Jan. 21];74(12):2114-21. Available from: https://jpma.org.pk/index.php/public_html/article/view/11128